ATE132870T1 - Pyrrolo(2,1-b)thiazol-derivate - Google Patents

Pyrrolo(2,1-b)thiazol-derivate

Info

Publication number
ATE132870T1
ATE132870T1 AT90113378T AT90113378T ATE132870T1 AT E132870 T1 ATE132870 T1 AT E132870T1 AT 90113378 T AT90113378 T AT 90113378T AT 90113378 T AT90113378 T AT 90113378T AT E132870 T1 ATE132870 T1 AT E132870T1
Authority
AT
Austria
Prior art keywords
group
substituents
alkyl group
moiety
aryl group
Prior art date
Application number
AT90113378T
Other languages
English (en)
Inventor
Norio Suzuki
-Chome Kitakasai
Atsushi Nakayama
Toru Hosokami
Masashi Hasegawa
Shuichi Yokohama
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE132870T1 publication Critical patent/ATE132870T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Pyrrole Compounds (AREA)
AT90113378T 1989-06-13 1990-07-12 Pyrrolo(2,1-b)thiazol-derivate ATE132870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15114189 1989-06-13

Publications (1)

Publication Number Publication Date
ATE132870T1 true ATE132870T1 (de) 1996-01-15

Family

ID=15512262

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90113378T ATE132870T1 (de) 1989-06-13 1990-07-12 Pyrrolo(2,1-b)thiazol-derivate

Country Status (23)

Country Link
US (1) US5098919A (de)
EP (1) EP0410224B1 (de)
JP (1) JP2875605B2 (de)
KR (1) KR910002874A (de)
CN (1) CN1025337C (de)
AT (1) ATE132870T1 (de)
AU (1) AU624724B2 (de)
CA (1) CA2021135A1 (de)
DD (1) DD296492A5 (de)
DE (1) DE69024713T2 (de)
DK (1) DK0410224T3 (de)
ES (1) ES2084622T3 (de)
FI (1) FI903511A0 (de)
GR (1) GR3018798T3 (de)
HU (1) HU207331B (de)
IE (1) IE902545A1 (de)
IL (1) IL95021A (de)
NO (1) NO903084L (de)
NZ (1) NZ234450A (de)
PT (1) PT94688A (de)
RU (2) RU1836374C (de)
YU (1) YU136490A (de)
ZA (1) ZA905407B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244892A1 (en) * 2004-02-27 2005-11-03 Lazar Mitchell A Resistin as a marker and therapeutic target for cardiovascular disease
ES2431578T3 (es) * 2008-04-09 2013-11-27 B.R.A.H.M.S Gmbh Proendotelina-1 para la predicción del consumo de oxígeno máximo disminuido

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) * 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
US4347186A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein

Also Published As

Publication number Publication date
CN1049350A (zh) 1991-02-20
HU207331B (en) 1993-03-29
YU136490A (sh) 1992-09-07
IL95021A0 (en) 1991-06-10
DD296492A5 (de) 1991-12-05
NZ234450A (en) 1991-10-25
RU1836374C (ru) 1993-08-23
HUT57221A (en) 1991-11-28
DK0410224T3 (da) 1996-02-05
AU5890490A (en) 1991-01-17
RU2026288C1 (ru) 1995-01-09
NO903084D0 (no) 1990-07-11
GR3018798T3 (en) 1996-04-30
AU624724B2 (en) 1992-06-18
KR910002874A (ko) 1991-02-26
HU904214D0 (en) 1990-12-28
US5098919A (en) 1992-03-24
EP0410224B1 (de) 1996-01-10
IL95021A (en) 1994-06-24
ES2084622T3 (es) 1996-05-16
EP0410224A1 (de) 1991-01-30
DE69024713D1 (de) 1996-02-22
JPH03128385A (ja) 1991-05-31
ZA905407B (en) 1991-04-24
CA2021135A1 (en) 1991-01-14
CN1025337C (zh) 1994-07-06
IE902545A1 (en) 1991-02-27
PT94688A (pt) 1991-03-20
DE69024713T2 (de) 1996-06-13
NO903084L (no) 1991-01-14
FI903511A0 (fi) 1990-07-11
JP2875605B2 (ja) 1999-03-31

Similar Documents

Publication Publication Date Title
FI906204A (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
DE10199003I1 (de) Substituierte Thiazolidinionderivate
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
FI882081A0 (fi) 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning.
ES474215A1 (es) Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio
FR2669927B1 (fr) Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE68917357D1 (de) Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
DK183789D0 (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
IL85768A (en) Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them
DE69024713T2 (de) Pyrrolo(2,1-b)thiazol-Derivate
NO905245L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
AU8003594A (en) Quinolinecarboxylic acid derivative and salt thereof
NZ240272A (en) Piperazine derivatives; pharmaceutical compositions and preparatory processes
NO177962C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-oxa-2-oxo-8-azaspiro[4,5Ådecan-derivater
AU8292787A (en) Fluorine-containing macrolide compounds and their use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee